Skip to search formSkip to main contentSkip to account menu

Tacalcitol

Known as: (+)-(5z,7e,24R)-9,10-Secocholesta-5,7,10(19)-Triene-1Alpha,3Beta,24-Triol, (1S,3R,5z,7e,24R)-9,10-Secocholesta-5,7,10-Triene-1,3,24-Triol, 1 alpha,24-dihydroxyvitamin D3, (1alpha,3beta,5Z,7E,24R)-isomer 
National Institutes of Health

Related topics

Related topics

1 relation
Tacalcitol 0.000004 MG/MG Topical Ointment

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Topische Therapie bei Psoriasis vulgaris – ein Behandlungspfad
Die topische Behandlung der Psoriasis und ihrer Sonderformen hat einen hohen Stellenwert im Praxisalltag. Sie ist… 
Review
2008
Review
2008
Cellular and molecular mechanisms involved in the action of vitamin D analogs targeting vitiligo depigmentation.
The active metabolite of vitamin D3 - 1,25-(OH)2D3 - exerts most of its physiological and pharmacological actions through its… 
Highly Cited
2006
Highly Cited
2006
Tacalcitol and narrow‐band phototherapy in patients with vitiligo
Background.  Vitiligo is a skin disease characterized by loss of normal pigmentation in the skin. Several treatments exist but… 
Highly Cited
2006
Highly Cited
2006
Topical tacalcitol and 308‐nm monochromatic excimer light: a synergistic combination for the treatment of vitiligo
Background/purpose: To study and compare the efficacy of combined 308‐nm monochromatic excimer light (MEL) therapy with… 
Highly Cited
2004
Highly Cited
2004
Efficacy of Treatment with Calcipotriol/Betamethasone Dipropionate Followed by Calcipotriol Alone Compared with Tacalcitol for the Treatment of Psoriasis vulgaris: A Randomised, Double-Blind Trial
Background: A two-compound product containing calcipotriol 50 µg/g and betamethasone dipropionate 0.5 mg/g (Daivobet®, Dovobet… 
2004
2004
Toxicity and antineoplastic effect of (24R)-1,24-dihydroxyvitamin D3 (PRI-2191)
Highly Cited
2002
Highly Cited
2002
Polymorphisms of vitamin D receptor gene in Japanese patients with psoriasis vulgaris.
Highly Cited
2002
Highly Cited
2002
Long‐term efficacy and safety of tacalcitol ointment in patients with chronic plaque psoriasis
Summary Background  As psoriasis patients often require continuous treatment optimal therapy has to provide efficacy and a good… 
Highly Cited
1997
Highly Cited
1997
Once daily treatment of psoriasis with tacalcitol compared with twice daily treatment with calcipotriol. A double‐blind trial
Once daily topical treatment of psoriasis with tacalcitol ointment (4μ/g) was compared with twice daily treatment with… 
Highly Cited
1996
Highly Cited
1996
Tacalcitol ointment in the treatment of psoriasis vulgaris:a multicentre, placebo‐controlled, double‐blind study on efficacy and safety
Summary Tacalcitol is a vitamin D analogue which has been developed for the therapy of psoriasis vulgaris. The treatment with a… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)